343 related articles for article (PubMed ID: 24486359)
21. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
de Boer PT; Backer JA; van Hoek AJ; Wallinga J
BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
[TBL] [Abstract][Full Text] [Related]
22. Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study.
Yue M; Dickens BL; Yoong JS; I-Cheng Chen M; Teerawattananon Y; Cook AR
Value Health; 2019 Dec; 22(12):1345-1354. PubMed ID: 31806190
[TBL] [Abstract][Full Text] [Related]
23. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old.
Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR
Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
25. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
Baguelin M; Camacho A; Flasche S; Edmunds WJ
BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis.
Orenstein EW; Orenstein LA; Diarra K; Djiteye M; Sidibé D; Haidara FC; Doumbia MF; Diallo F; Coulibaly F; Keita AM; Onwuchekwa U; Teguete I; Tapia MD; Sow SO; Levine MM; Rheingans R
PLoS One; 2017; 12(2):e0171499. PubMed ID: 28170416
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
30. Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old.
Smith KJ; Nowalk MP; Lin CJ; Zimmerman RK
Hum Vaccin Immunother; 2017 Oct; 13(10):2207-2212. PubMed ID: 28829719
[TBL] [Abstract][Full Text] [Related]
31. Cost-Effectiveness of the 4 Pillars Practice Transformation Program to Improve Vaccination of Adults Aged 65 and Older.
Smith KJ; Zimmerman RK; Nowalk MP; Lin CJ
J Am Geriatr Soc; 2017 Apr; 65(4):763-768. PubMed ID: 28024090
[TBL] [Abstract][Full Text] [Related]
32. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.
Myers ER; Misurski DA; Swamy GK
Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S128-40. PubMed ID: 21640230
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
[TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of pneumococcal and influenza vaccination standing order programs.
Lin CJ; Zimmerman RK; Smith KJ
Am J Manag Care; 2013 Jan; 19(1):e30-7. PubMed ID: 23379777
[TBL] [Abstract][Full Text] [Related]
37. Influenza cost and cost-effectiveness studies globally--a review.
Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
[TBL] [Abstract][Full Text] [Related]
38. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.
Nichol KL; Mendelman P
Virus Res; 2004 Jul; 103(1-2):3-8. PubMed ID: 15163481
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly.
Kim M; Yoo BK
Value Health; 2015 Jul; 18(5):622-30. PubMed ID: 26297090
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness study on influenza prevention in Hong Kong.
Fitzner KA; Shortridge KF; McGhee SM; Hedley AJ
Health Policy; 2001 Jun; 56(3):215-34. PubMed ID: 11399347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
